You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 12, 2024

TIVORBEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Tivorbex patents expire, and when can generic versions of Tivorbex launch?

Tivorbex is a drug marketed by Genus and is included in one NDA. There are three patents protecting this drug.

This drug has thirty-seven patent family members in twenty-one countries.

The generic ingredient in TIVORBEX is indomethacin. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the indomethacin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tivorbex

A generic version of TIVORBEX was approved as indomethacin by CHARTWELL MOLECULES on August 6th, 1984.

  Try a Trial

Summary for TIVORBEX
International Patents:37
US Patents:3
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 164
Clinical Trials: 2
Patent Applications: 4,362
Formulation / Manufacturing:see details
Drug Prices: Drug price information for TIVORBEX
What excipients (inactive ingredients) are in TIVORBEX?TIVORBEX excipients list
DailyMed Link:TIVORBEX at DailyMed
Drug patent expirations by year for TIVORBEX
Drug Prices for TIVORBEX

See drug prices for TIVORBEX

Recent Clinical Trials for TIVORBEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sen-Jam PharmaceuticalPhase 2
National University, SingaporePhase 2
Iroko Pharmaceuticals, LLCPhase 2

See all TIVORBEX clinical trials

US Patents and Regulatory Information for TIVORBEX

TIVORBEX is protected by three US patents.

Patents protecting TIVORBEX

Formulation of indomethacin
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Formulation of indomethacin
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Formulation of indomethacin
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: TREATMENT OF PAIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genus TIVORBEX indomethacin CAPSULE;ORAL 204768-001 Feb 24, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Genus TIVORBEX indomethacin CAPSULE;ORAL 204768-002 Feb 24, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Genus TIVORBEX indomethacin CAPSULE;ORAL 204768-001 Feb 24, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Genus TIVORBEX indomethacin CAPSULE;ORAL 204768-001 Feb 24, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Genus TIVORBEX indomethacin CAPSULE;ORAL 204768-002 Feb 24, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Genus TIVORBEX indomethacin CAPSULE;ORAL 204768-002 Feb 24, 2014 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TIVORBEX

See the table below for patents covering TIVORBEX around the world.

Country Patent Number Title Estimated Expiration
Eurasian Patent Organization 201171286 НОВАЯ ТЕХНОЛОГИЯ ИЗГОТОВЛЕНИЯ ИНДОМЕТАЦИНА ⤷  Try a Trial
Singapore 10201401695V A NOVEL FORMULATION OF INDOMETHACIN ⤷  Try a Trial
Brazil PI1014275 nova formulação de indometacina ⤷  Try a Trial
New Zealand 595986 A novel formulation of indomethacin ⤷  Try a Trial
Denmark 2421513 ⤷  Try a Trial
Morocco 33296 صيغة جديدة لإندوميثاسين ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.